Azathioprine with Allopurinol Is a Promising First-Line Therapy for Inflammatory Bowel Diseases

被引：0

作者：

Elsa L. S. A. van Liere

Ahmed B. Bayoumy

Chris J. J. Mulder

Ben Warner

Bu Hayee

Bilal A. Mateen

Jonathan D. Nolan

Nanne K. H. de Boer

Simon H. C. Anderson

Azhar R. Ansari

机构：

[1] Amsterdam UMC,Faculty of Medicine

[2] VU University Medical Centre,Department of Gastroenterology and Hepatology

[3] Surrey and Sussex NHS,Department of Gastroenterology and Hepatology

[4] Easy Surrey Hospital,Department of Gastroenterology and Hepatology

[5] AGEM Research Institute,IBD Service

[6] Amsterdam UMC,undefined

[7] VU University Medical Centre,undefined

[8] Guy’s and St Thomas’ NHS Foundation Trust,undefined

[9] King’s College Hospital NHS Foundation Trust,undefined

来源：

Digestive Diseases and Sciences | 2022年 / 67卷

关键词：

Azathioprine; Allopurinol; Thiopurines; Inflammatory bowel disease; Drug repositioning;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：4008 / 4019

页数：11

共 50 条

[21] Loss of response after first-line biologic therapy in patients with inflammatory bowel disease: practical approach and management
Busacca, A.
Scrivo, B.
Giuffrida, E.
Guida, L.
Carrozza, L.
Calvaruso, V.
Cappello, M.
JOURNAL OF CROHNS & COLITIS, 2020, 14 : S299 - S299
[22] ULTRASOUND - FIRST-LINE IMAGING MODALITY IN EVALUATION OF THE INFLAMMATORY BOWEL LESIONS IN CHILDREN
Grzegorczyk, Magdalena
Kuczynska, Maryla
Siejka, Karolina
Zbroja, Monika
Cyranka, Weronika
Piekarska, Monika
Nowakowska, Malgorzata
Wozniak, Magdalena Maria
Brodzisz, Agnieszka
INFLAMMATORY BOWEL DISEASES, 2021, 27 : S11 - S12
[23] ULTRASOUND - FIRST-LINE IMAGING MODALITY IN EVALUATION OF THE INFLAMMATORY BOWEL LESIONS IN CHILDREN
Grzegorczyk, Magdalena
Kuczynska, Maryla
Siejka, Karolina
Zbroja, Monika
Cyranka, Weronika
Piekarska, Monika
Nowakowska, Malgorzata
Wozniak, Magdalena Maria
Brodzisz, Agnieszka
GASTROENTEROLOGY, 2021, 160 (03) : S15 - S16
[24] Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease patients with inadequate thiopurine metabolite concentrations
Ivanka Curkovic
Katharina M. Rentsch
Pascal Frei
Michael Fried
Gerhard Rogler
Gerd A. Kullak-Ublick
Alexander Jetter
European Journal of Clinical Pharmacology, 2013, 69 : 1521 - 1531
[25] HOW MUCH ALLOPURINOL IS NEEDED TO OPTIMIZE AZATHIOPRINE THERAPY IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH INADEQUATE THIOPURINE METABOLITE CONCENTRATIONS?
Curkovic, I.
Rentsch, K.
Fried, M.
Rogler, G.
Kullak-Ublick, G. A.
Jetter, A.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 : 30 - 30
[26] Low allopurinol doses are sufficient to optimize azathioprine therapy in inflammatory bowel disease patients with inadequate thiopurine metabolite concentrations
Curkovic, Ivanka
Rentsch, Katharina M.
Frei, Pascal
Fried, Michael
Rogler, Gerhard
Kullak-Ublick, Gerd A.
Jetter, Alexander
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (08) : 1521 - 1531
[27] Monitoring and Safety of Azathioprine Therapy in Inflammatory Bowel Disease
Kim, Mi Jin
Choe, Yon Ho
PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION, 2013, 16 (02) : 65 - 70
[28] AZATHIOPRINE THERAPY FOR INFLAMMATORY BOWEL DISEASE - A PRELIMINARY REPORT
BROWN, CH
ACHKAR, E
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1970, 54 (04): : 363 - &
[29] A first for first-line therapy in NSCLC
Rebecca Kirk
Nature Reviews Clinical Oncology, 2011, 8 (12) : 691 - 691
[30] Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy: a real-world, nationwide cohort of patients with inflammatory bowel diseases
Attauabi, Mohamed
Hoglund, Camilla
Fassov, Janne
Pedersen, Kenneth Bo
Hansen, Heidi Bansholm
Wildt, Signe
Jensen, Michael Dam
Neumann, Anders
Lind, Cecilie
Jacobsen, Henrik Albaek
Popa, Ana-Maria
Kjeldsen, Jens
Pedersen, Natalia
Molazahi, Akbar
Haderslev, Kent
Aalykke, Claus
Knudsen, Torben
Cebula, Wojciech
Munkholm, Pia
Bendtsen, Flemming
Seidelin, Jakob Benedict
Burisch, Johan
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2021, 56 (09) : 1040 - 1048

← 1 2 3 4 5 →